Amikacin PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering a Amikacin PCD pharma franchise across India. Our portfolio spans 4 Amikacin formulations in Injection form, backed by consistent quality and monopoly-based distribution rights for our franchise partners.

What is Amikacin?

Amikacin is an aminoglycoside antibiotic that binds to the bacterial 30S ribosomal subunit, blocking protein synthesis and producing a rapid bactericidal effect. It is particularly valuable against serious Gram-negative infections, including many strains resistant to other aminoglycosides. Its profile is documented on PubChem.

Therapeutic Applications

Amikacin injection is used to treat severe Gram-negative infections such as septicaemia, complicated urinary tract, intra-abdominal, bone and soft-tissue infections, and forms part of second-line multidrug-resistant tuberculosis regimens. It is prescribed mainly by physicians, intensivists, pulmonologists and surgeons in hospital settings.

Why Amikacin is a High-Potential Molecule for Distributors

Amikacin is a hospital and critical-care injectable that sits on the WHO Model List of Essential Medicines, giving it durable institutional demand from nursing homes, hospitals and ICUs. As a high-value sterile antibiotic with limited OTC substitution, it delivers healthy per-unit margins and steady tender and prescription-driven off-take, making it an attractive addition to a distributor's critical-care and injectable portfolio.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers district and state-wise monopoly rights, WHO-GMP certified and DCGI-approved manufacturing, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent supply and billing model helps you build a profitable, protected business in your territory.

References

1. PubChem — Amikacin
2. MedlinePlus — Antibiotics
3. PubMed — Amikacin literature